Author Information
Carlota Gudiol is a prominent researcher in the field of infectious diseases, affiliated with the Department of Infectious Diseases at Hospital Universitari de Bellvitge, IDIBELL (Institut d'Investigació Biomèdica de Bellvitge), and the University of Barcelona in Barcelona, Spain. Additionally, she is associated with the Department of Oncology at Institut Català d'Oncologia, l'Hospitalet, University of Barcelona, as well as the REIPI (Spanish Network for Research in Infectious Diseases) in Madrid, Spain. Her research is primarily focused on tackling infectious diseases, with a particular emphasis on epidemiology and treatment strategies.Research Contributions
Carlota Gudiol has made significant contributions to the understanding and management of infectious diseases, with a particular focus on COVID-19, antibiotic resistance, and infections in neutropenic patients. Her research includes a range of studies, from clinical trials assessing treatments for COVID-19, such as the use of icatibant and convalescent plasma, to investigations into the efficacy of antibiotics for treating infections in cancer patients. Her work also extends to understanding the epidemiology of long COVID symptoms and the impact of successive COVID-19 waves in Spain.Aliases
Carlota Gudiol is also known by the aliases C. Gudiol and C Gudiol. These variations may appear in different publications or databases.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
5503 |
| H-index |
38 |
| Total Number of Papers |
142 |
